Verdure Sciences announces two recent patents granted from the United States Patent and Trademark Office (USPTO) for applications covering the composition and methodology of POMELLA® Pomegranate Extract brands.
U.S. Patents 7,897,791 and 7,919,636, granted in 2011, are in addition to U.S. Patent 7,638,640 secured by Verdure Sciences in 2009.
"The new patents mark a significant milestone for the POMELLA® brand, and we are proud to see our efforts validated by further patent protections," said Sonya Cropper, V.P. Marketing for Verdure Sciences. “The POMELLA® brand continues to set industry standards in pomegranate bioavailability, quality, and punicalagin content.”
The POMELLA® Pomegranate Extract brand product, developed by a top California research university, is clinically researched and standardized to a patented composition, including the antioxidant-rich punicalagins.
Manufactured under GMP-registered, ISO-certified standards, POMELLA® Extract is 100% natural, Kosher-certified and GMO-free. More information, including a new White Paper titled “New Research on Pomegranate Punicalagins” is now available at http://www.pomextract.com/Pomella-White-Paper-Form.html.
About Verdure Sciences™:
Verdure Sciences offers innovative bionutritionals through the integration of agricultural networks, manufacturing control, and university-based, cutting-edge research. With an expanding pipeline of proprietary, standardized botanical ingredients supported by pharmacokinetic, pharmacodynamic, and clinical research profiles, we work toward our unified vision to offer access to safe, effective health solutions to populations worldwide.